Evolent Health Inc (NYSE:EVH)’s share price traded up 5.7% during mid-day trading on Thursday . The stock traded as high as $14.38 and last traded at $13.95. 1,709,600 shares traded hands during mid-day trading, an increase of 49% from the average session volume of 1,143,857 shares. The stock had previously closed at $13.20.

A number of equities research analysts recently weighed in on EVH shares. Zacks Investment Research lowered Evolent Health from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. Cowen restated an “outperform” rating and set a $29.00 price objective (down previously from $33.00) on shares of Evolent Health in a research report on Friday, October 6th. Canaccord Genuity restated a “buy” rating and set a $32.00 price objective on shares of Evolent Health in a research report on Friday, October 6th. Robert W. Baird restated an “outperform” rating and set a $25.00 price objective (down previously from $35.00) on shares of Evolent Health in a research report on Tuesday, September 26th. They noted that the move was a valuation call. Finally, SunTrust Banks restated a “buy” rating and set a $30.00 price objective on shares of Evolent Health in a research report on Wednesday, September 20th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $28.00.

The firm has a market capitalization of $1,130.00 and a PE ratio of -12.81. The company has a quick ratio of 3.34, a current ratio of 3.34 and a debt-to-equity ratio of 0.11.

Evolent Health (NYSE:EVH) last announced its earnings results on Thursday, November 2nd. The technology company reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.04. The firm had revenue of $107.90 million for the quarter, compared to the consensus estimate of $104.49 million. Evolent Health had a negative return on equity of 5.05% and a negative net margin of 15.86%. The business’s quarterly revenue was up 79.2% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.26) EPS. analysts forecast that Evolent Health Inc will post -0.55 earnings per share for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC lifted its holdings in Evolent Health by 117.7% during the 2nd quarter. FMR LLC now owns 9,864,775 shares of the technology company’s stock worth $250,073,000 after buying an additional 5,333,252 shares during the period. JPMorgan Chase & Co. lifted its holdings in Evolent Health by 37.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 7,465,019 shares of the technology company’s stock worth $136,236,000 after buying an additional 2,026,893 shares during the period. Vanguard Group Inc. lifted its holdings in Evolent Health by 48.9% during the 2nd quarter. Vanguard Group Inc. now owns 3,769,869 shares of the technology company’s stock worth $95,566,000 after buying an additional 1,237,941 shares during the period. TimesSquare Capital Management LLC lifted its holdings in Evolent Health by 5.7% during the 3rd quarter. TimesSquare Capital Management LLC now owns 1,592,300 shares of the technology company’s stock worth $28,343,000 after buying an additional 86,300 shares during the period. Finally, Eagle Asset Management Inc. lifted its holdings in Evolent Health by 40.6% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,529,943 shares of the technology company’s stock worth $28,609,000 after buying an additional 442,058 shares during the period. 95.38% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Evolent Health (EVH) Trading 5.7% Higher” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/evolent-health-evh-trading-5-7-higher/1803361.html.

About Evolent Health

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.